D. E. Shaw & Co., Inc. Thermo Fisher Scientific Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$528.82 - $599.43 $13.4 Million - $15.2 Million	-25,400 Reduced 66.67%	12,700 $7.38 Million
Q4 2023 Feb 14, 2024	BUY	$431.41 - $532.94 $11.6 Million - $14.3 Million	26,900 Added 240.18%	38,100 $20.2 Million
Q3 2023 Nov 14, 2023	BUY	$498.29 - $574.41 $996,580 - $1.15 Million	2,000 Added 21.74%	11,200 $5.67 Million
Q2 2023 Aug 14, 2023	SELL	$508.46 - $591.13 $4.22 Million - $4.91 Million	-8,300 Reduced 47.43%	9,200 $4.8 Million
Q1 2023 May 15, 2023	SELL	$535.0 - $604.82 $24.4 Million - $27.6 Million	-45,600 Reduced 72.27%	17,500 $10.1 Million
Q4 2022 Feb 14, 2023	BUY	$484.71 - $571.37 $6.83 Million - $8.06 Million	14,100 Added 28.78%	63,100 $34.8 Million
Q3 2022 Nov 14, 2022	SELL	$507.19 - $604.49 $2.54 Million - $3.02 Million	-5,000 Reduced 9.26%	49,000 $24.9 Million
Q2 2022 Aug 15, 2022	SELL	$500.9 - $612.21 $12.8 Million - $15.6 Million	-25,500 Reduced 32.08%	54,000 $29.3 Million
Q1 2022 May 16, 2022	BUY	$524.0 - $644.92 $25.9 Million - $31.9 Million	49,500 Added 165.0%	79,500 $47 Million
Q4 2021 Feb 14, 2022	BUY	$569.0 - $667.24 $11.4 Million - $13.3 Million	20,000 Added 200.0%	30,000 $20 Million
Q3 2021 Nov 15, 2021	SELL	$509.53 - $609.78 $1.63 Million - $1.95 Million	-3,200 Reduced 24.24%	10,000 $5.71 Million
Q2 2021 Aug 16, 2021	BUY	$441.0 - $508.24 $4.85 Million - $5.59 Million	11,000 Added 500.0%	13,200 $6.66 Million
Q1 2018 May 15, 2018	BUY	$192.98 - $224.11 $424,556 - $493,042	2,200 New	2,200 $454,000

2,833

331M

2.37M

2.75M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $212B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.